MacroGenics (MGNX) PT Raised to $24 at BTIG, 'Discussions with Physicians Increase our Confidence in Vobra Duo’s Profile'

Go back to MacroGenics (MGNX) PT Raised to $24 at BTIG, 'Discussions with Physicians Increase our Confidence in Vobra Duo’s Profile'

MacroGenics (MGNX) PT Raised to $23 at Barclays

February 29, 2024 3:42 AM EST

Barclays analyst Peter Lawson raised the price target on MacroGenics (NASDAQ: MGNX) to $23.00 (from $12.00) while maintaining a Overweight rating.... More